Cargando…
Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA
Analysis of the methylome of tumor cell-free deoxyribonucleic acid (DNA; cfDNA) has emerged as a powerful non-invasive technique for cancer subtyping and prognosis. However, its application is frequently hampered by the quality and total cfDNA yield. Here, we demonstrate the feasibility of very low-...
Autores principales: | Trinidad, Eva María, Vidal, Enrique, Coronado, Esther, Esteve-Codina, Anna, Castel, Victoria, Cañete, Adela, Gut, Marta, Heath, Simon, Font de Mora, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851319/ https://www.ncbi.nlm.nih.gov/pubmed/36611239 http://dx.doi.org/10.1093/bib/bbac575 |
Ejemplares similares
-
Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas
por: Trinidad, Eva María, et al.
Publicado: (2023) -
Intratumoral immunosuppression profiles in 11q‐deleted neuroblastomas provide new potential therapeutic targets
por: Coronado, Esther, et al.
Publicado: (2021) -
Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor
por: Hämmerle, Barbara, et al.
Publicado: (2013) -
TIAM1 variants improve clinical outcome in neuroblastoma
por: Sanmartín, Elena, et al.
Publicado: (2017) -
Two independent epigenetic biomarkers predict survival in neuroblastoma
por: Yáñez, Yania, et al.
Publicado: (2015)